Case number 1:23-cv-00715
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 25, 2023 | 10 | ORAL ORDER. Pursuant to Plaintiffs' Notice of Dismissal at Dkt. No. 9 , the action is hereby dismissed. The court directs the clerk to close the case. Signed by Judge William C. Bryson on 9/25/2023. (ndw) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | N/A | CASE CLOSED (smg) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 11 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,284,474 B2; 7,896,264 B2; 7,396,341 B2; 9,027,967 B2; 7,837,235 B2; and 8,733,341 B2. (smg) (Entered: 09/25/2023) (2) |
| Sep 22, 2023 | 9 | NOTICE of Voluntary Dismissal by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Raucci, Anthony) (Entered: 09/22/2023) (2) |
| Sep 15, 2023 | 8 | Letter to The Honorable William C. Bryson from Anthony D. Raucci regarding Status Report - re (7 in 1:23-cv-00716-WCB, 7 in 1:23-cv-00715-WCB) Oral Order. (Raucci, Anthony) (Entered: 09/15/2023) (2) |
| Sep 8, 2023 | 7 | ORAL ORDER: By Friday, September 15, 2023, the plaintiffs should file a letter updating the court on the status of this case, including any efforts to serve the defendants. Signed by Judge William C. Bryson on 9/8/2023. (dds) (Entered: 09/08/2023) (0) |
| Jul 10, 2023 | N/A | Case Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. Associated Cases: 1:23-cv-00715-WCB, 1:23-cv-00716-WCB (rjb) (Entered: 07/10/2023) (0) |
| Jul 5, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:23-cv-00715-GBW, 1:23-cv-00716-GBW (rjb) (Entered: 07/05/2023) (0) |
| Jun 30, 2023 | 1 | Complaint* (1) |
| Jun 30, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 06/30/2023) (3) |
| Jun 30, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/2023. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 11/19/2025. (apk) (Entered: 06/30/2023) (1) |
| Jun 30, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,284,474 B2 ;7,896,264 B2 ;7,396,341 B2 ;9,027,967 B2 ;7,837,235 B2 ;8,733,341 B2. (apk) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (apk) (Entered: 06/30/2023) (1) |
| Jun 30, 2023 | 6 | Summons Issued as to Anobri Pharmaceuticals US, LLC on 6/30/2023; NanChang Anovent Pharmaceutical Co., Ltd. on 6/30/2023; Shaghai Anovent Pharmaceutical Co., Ltd. on 6/30/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 06/30/2023) (0) |
